IL13 and primary biliary cholangitis: However, the strong release of IL-13 and IL-10 by PBMC from PSC-patients – a phenomenon which we did not observe with PBMC from PBC-patients (own unpublished observation) – also argues in favour of TH2-mechanisms involved in PSC as already shown for autoimmune pancreato-cholangitis [34].